ROST
63
12
MET
72
5
NVDA
56
-4
PEP
48
6
PM
62
-2
PAYX
53
2
SIG
52
3
VNO
60
10
EXC
53
-3
ADSK
70
2
AIV
72
2
CPB
30
6
NOC
43
11
HP
48
3
NAVI
52
5
DG
6
2
PBI
69
4
ZION
65
2
NDAQ
62
2
SLB
55
2
ROST
63
12
MET
72
5
NVDA
56
-4
PEP
48
6
PM
62
-2
PAYX
53
2
SIG
52
3
VNO
60
10
EXC
53
-3
ADSK
70
2
AIV
72
2
CPB
30
6
NOC
43
11
HP
48
3
NAVI
52
5
DG
6
2
PBI
69
4
ZION
65
2
NDAQ
62
2
SLB
55
2
Financhill
Back

Armata Pharmaceuticals 10K Form

Buy
61

ARMP
Armata Pharmaceuticals

Last Price:
2.29
Seasonality Move:
35.12%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ARMP News And Ratings

See the #1 stock for the next 7 days that we like better than ARMP

ARMP Financial Statistics

Sales & Book Value

Annual Sales: $820K
Cash Flow: $-9.2M
Price / Cash Flow: 0
Annual Sales: $-1.41
Price / Book: 0

Profitability

EPS (TTM): -1.64000
Net Income (TTM): $-41.36M
Gross Margin: $410K
Return on Equity: 0%
Return on Assets: 0%

Armata Pharmaceuticals Earnings Forecast

Key Armata Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 19 years for ARMP is 100.24%.
  • The Selling, General & Administrative Expenses for ARMP have been equal to 971.46% of Gross Profit Margin.
  • The Interest Expense is -3.80% of Operating Income.
  • Per Share Earnings over the last 28 years have been positive in 11 years.

Armata Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYAM
Industry: Biotechnology
Sector: Health Care
Current Symbol: ARMP
CUSIP: 04216R
Website: armatapharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ARMP Technical Analysis vs Fundamental Analysis

Buy
61
Armata Pharmaceuticals (ARMP) is a Buy

Is Armata Pharmaceuticals a Buy or a Sell?